187 related articles for article (PubMed ID: 18478455)
1. [Effectiveness results of olanzapine in acute psychotic patients with agitation in the emergency room setting: results from NATURA study].
Escobar R; San L; Pérez V; Olivares JM; Polavieja P; López-Carrero C; Casillas M; Montoya A
Actas Esp Psiquiatr; 2008; 36(3):151-7. PubMed ID: 18478455
[TBL] [Abstract][Full Text] [Related]
2. Olanzapine orally-disintegrating tablet in severe psychotic agitation: a naturalistic study.
Pascual JC; Pérez V; Martín JL; Safont G; Puigdemont D; Alvarez E
Actas Esp Psiquiatr; 2007; 35(1):47-51. PubMed ID: 17323225
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics of agitated psychotic patients treated with an oral antipsychotics attended in the emergency room setting: NATURA study.
Montoya A; San L; Manuel Olivares J; Pérez-Sola V; Casillas M; López-Carrero C; Polavieja P; Escobar R
Int J Psychiatry Clin Pract; 2008; 12(2):127-33. PubMed ID: 24916623
[TBL] [Abstract][Full Text] [Related]
4. Validation of the Excited Component of the Positive and Negative Syndrome Scale (PANSS-EC) in a naturalistic sample of 278 patients with acute psychosis and agitation in a psychiatric emergency room.
Montoya A; Valladares A; Lizán L; San L; Escobar R; Paz S
Health Qual Life Outcomes; 2011 Mar; 9():18. PubMed ID: 21447155
[TBL] [Abstract][Full Text] [Related]
5. Olanzapine in the treatment of agitation in hospitalized patients with schizophrenia and schizoaffective and schizofreniform disorders.
Turczyński J; Bidzan L; Staszewska-Małys E
Med Sci Monit; 2004 May; 10(5):PI74-80. PubMed ID: 15114282
[TBL] [Abstract][Full Text] [Related]
6. Oral risperidone, olanzapine and quetiapine versus haloperidol in psychotic agitation.
Villari V; Rocca P; Fonzo V; Montemagni C; Pandullo P; Bogetto F
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):405-13. PubMed ID: 17900775
[TBL] [Abstract][Full Text] [Related]
7. [A naturalistic study: 100 consecutive episodes of acute agitation in a psychiatric emergency department].
Pascual JC; Madre M; Puigdemont D; Oller S; Corripio I; Díaz A; Faus G; Perez V; Alvarez E
Actas Esp Psiquiatr; 2006; 34(4):239-44. PubMed ID: 16823684
[TBL] [Abstract][Full Text] [Related]
8. Treatment of severe agitation with olanzapine in 166 patients with schizophrenia, schizoaffective, or bipolar I disorder.
Lambert M; Huber CG; Naber D; Schacht A; Wagner TT; Hundemer HP; Karow A; Schimmelmann BG
Pharmacopsychiatry; 2008 Sep; 41(5):182-9. PubMed ID: 18763220
[TBL] [Abstract][Full Text] [Related]
9. Olanzapine orally disintegrating tablets (Zyprexa Zydis) rapidly improve excitement components in the acute phase of first-episode schizophrenic patients: an open-label prospective study.
Hori H; Ueda N; Yoshimura R; Yamamoto H; Wani K; Etoh Y; Haraga K; Kitahara J; Nakamura J
World J Biol Psychiatry; 2009; 10(4 Pt 3):741-5. PubMed ID: 19707954
[TBL] [Abstract][Full Text] [Related]
10. An observational study of the effectiveness and safety of intramuscular olanzapine in the treatment of acute agitation in patients with bipolar mania or schizophrenia/schizoaffective disorder.
Centorrino F; Meyers AL; Ahl J; Cincotta SL; Zun L; Gulliver AH; Kinon BJ; Houston JP
Hum Psychopharmacol; 2007 Oct; 22(7):455-62. PubMed ID: 17708578
[TBL] [Abstract][Full Text] [Related]
11. Comparison of intramuscular olanzapine, orally disintegrating olanzapine tablets, oral risperidone solution, and intramuscular haloperidol in the management of acute agitation in an acute care psychiatric ward in Taiwan.
Hsu WY; Huang SS; Lee BS; Chiu NY
J Clin Psychopharmacol; 2010 Jun; 30(3):230-4. PubMed ID: 20473056
[TBL] [Abstract][Full Text] [Related]
12. A naturalistic multicenter study of intramuscular olanzapine in the treatment of acutely agitated manic or schizophrenic patients.
San L; Arranz B; Querejeta I; Barrio S; De la Gándara J; Pérez V
Eur Psychiatry; 2006 Dec; 21(8):539-43. PubMed ID: 16697151
[TBL] [Abstract][Full Text] [Related]
13. Comparison of risperidone orodispersible tablet and intramuscular haloperidol in the treatment of acute psychotic agitation: a randomized open, prospective study.
Lim HK; Kim JJ; Pae CU; Lee CU; Lee C; Paik IH
Neuropsychobiology; 2010; 62(2):81-6. PubMed ID: 20523078
[TBL] [Abstract][Full Text] [Related]
14. Intramuscular olanzapine in patients with schizophrenia: an observational study in an emergency room.
Damsa C; Adam E; Lazignac C; De Gregorio F; Mihai A; Lejeune J; Sarasin F; Allen MH
Bull Soc Sci Med Grand Duche Luxemb; 2008; (2):209-16. PubMed ID: 18561597
[TBL] [Abstract][Full Text] [Related]
15. Intramuscular olanzapine in patients with borderline personality disorder: an observational study in an emergency room.
Damsa C; Adam E; De Gregorio F; Cailhol L; Lejeune J; Lazignac C; Allen MH
Gen Hosp Psychiatry; 2007; 29(1):51-3. PubMed ID: 17189746
[TBL] [Abstract][Full Text] [Related]
16. Effective resolution with olanzapine of acute presentation of behavioral agitation and positive psychotic symptoms in schizophrenia.
Kinon BJ; Roychowdhury SM; Milton DR; Hill AL
J Clin Psychiatry; 2001; 62 Suppl 2():17-21. PubMed ID: 11232746
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological management of agitation in emergency settings.
Yildiz A; Sachs GS; Turgay A
Emerg Med J; 2003 Jul; 20(4):339-46. PubMed ID: 12835344
[TBL] [Abstract][Full Text] [Related]
18. Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia.
Meehan KM; Wang H; David SR; Nisivoccia JR; Jones B; Beasley CM; Feldman PD; Mintzer JE; Beckett LM; Breier A
Neuropsychopharmacology; 2002 Apr; 26(4):494-504. PubMed ID: 11927174
[TBL] [Abstract][Full Text] [Related]
19. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and tolerability of olanzapine in the treatment of adolescents with schizophrenia and related psychotic disorders: results from a large, prospective, open-label study.
Dittmann RW; Meyer E; Freisleder FJ; Remschmidt H; Mehler-Wex C; Junghanss J; Hagenah U; Schulte-Markwort M; Poustka F; Schmidt MH; Schulz E; Mästele A; Wehmeier PM
J Child Adolesc Psychopharmacol; 2008 Feb; 18(1):54-69. PubMed ID: 18294089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
